Recruiting now—Ages 18 Years and up
Precision Imaging to Evaluate Kaposi Sarcoma (PRIME-KS): A Device Feasibility Trial
Sponsor: Washington University School of Medicine · NCT06751355 on ClinicalTrials.gov ↗
Conditions studied
Kaposi Sarcoma
What it tests
- SkinScan3D cameradevice
Where it's running1 site
- Recruiting now
Washington University School of Medicine
St Louis, Missouri 63110
- Lee Ratner, M.D., Ph.D.(contact)314-362-8836[email protected]
- Lee Ratner, M.D., Ph.D.(principal investigator)
- Thomas Odeny, MBChB, MPH, Ph.D.(sub investigator)
- Feng Gao, Ph.D.(sub investigator)
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Eligibility Criteria: * Have been diagnosed with histologically or cytologically proven Kaposi sarcoma (KS). * Patients may be off treatment or on treatment for their KS. * Has at least 3 cutaneous Kaposi sarcoma lesions. * At least 18 years of age. * Ability to understand and willingness to sign an IRB approved written informed consent document.
Updated 2026-03-25 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.